Clinical Pharmacology and Dietary Supplements: An Evolving Relationship

被引:11
|
作者
Gurley, B. J. [1 ]
机构
[1] Univ Arkansas Med Sci, Coll Pharm, Dept Pharmaceut Sci, Little Rock, AR 72205 USA
关键词
ST-JOHNS-WORT; DRUG-INTERACTIONS; EPHEDRA; CAFFEINE; CONTAMINATION; PRODUCTS; SAFETY;
D O I
10.1038/clpt.2009.245
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Since their introduction in 1994, dietary supplements have gained a significant foothold in the American health-care system. The fact that almost 20% of US adults spend a total of $14 billion annually on nonvitamin, nonmineral "natural" products(1) is a testament to the popularity of these supplements. However, most consumers, and many health-care professionals, are unaware that clinical pharmacology has played a key role in assessing the safety of herbal supplements. In the process, a productive-though often stormy-relationship has developed between clinical pharmacology and the dietary supplements industry.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 50 条